In tumors with missing or mutated BRCA genes, PARP inhibitors plus other drugs have worked well—but the cancer often becomes drug-resistant.

New study finds that simple cysts should be considered normal and ignored.

Physicians recognize that ovarian cancer isn’t a single disease but a group of related disorders with distinct genetic and cellular features

PARP inhibitor demonstrates unprecedented improvement in progression-free survival.

Other pain relievers might raise the odds, however.

September is Ovarian Cancer Awareness Month

The search continues for new biomarkers, better outcomes and, yes, cures for this deadly disease.

Genetic mutation raises the risk of breast, ovarian and prostate cancers.

Talking with other people who’ve shared your experience with breast cancer can make all the difference in the world.